Background. The envelope glycoprotein gB of human cytomegalovirus (CMV) occ
urs as one of four main genotypes, Some previous studies have proposed a re
lationship of CMV gB genotype to the frequency of symptomatic infection and
to clinical outcomes in both transplant and human immunodeficiency virus-i
nfected populations. Our aim was to define the distribution of CMV gB genot
ypes and the impact on acute cellular rejection and graft/patient survival
after orthotopic liver transplantation (OLT).
Methods. Between October 1988 and December 1996, 325 patients underwent cyc
losporine-based OLT at our center. CMV infection was surveyed prospectively
and defined as viral isolation from blood or urine; 53 (16%) patients had
detectable CMV, Isolates were genotyped by polymerase chain reaction amplif
ication and restriction digest analysis.
Results. The distribution of CMV genotypes was: gB1, 19 (36%) patients; gB2
, 15 (28%) patients; gB3, 13 (24%) patients; and gB4, 4 (8%) patients. Two
patients (4%) had mixed infection (1 + 3, 1 + 4), Age, preOLT diagnosis, us
e of ganciclovir prophylaxis, basal immunosuppression, mean number of HLA d
onor/recipient mismatches, and United Network of Organ Sharing status were
comparable among patients with different genotypes. Patients with gB1 had a
significantly higher mean number of acute rejection episodes (1.52+/-0.30
vs. 0.67+/-0.22; P=0.027). However, there was no difference in rejection se
verity, including OKT3 usage or FK506 conversion, or development of chronic
rejection among patients with different genotypes. The gB genotype did not
affect the development of symptomatic or tissue-invasive CMV disease, dete
cted in 15 patients. Actuarial rates of patient (odds ratio [OR] 3.0; confi
dence interval [CI] 1.49-6.0) and graft (OR 2.57; CI 1.25-5.22) survival we
re significantly diminished in the group with CMV infection versus those wi
thout CMV (P<0.0001 for both), but there was no association with CMV genoty
pe.
Conclusions. (1) Patients with CMV infection had significantly reduced pati
ent and graft survival rates at 1 and 5 years after OLT as compared with OL
T recipients without CMV infection. (2) CMV genotype gB1 was associated wit
h a higher mean number of acute rejection episodes.